Search for: "Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S"
Results 21 - 40
of 46
Sort by Relevance
|
Sort by Date
5 Dec 2011, 12:40 pm
Transcripts from today’s arguments in Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
5 Dec 2011, 10:38 am
In Caraco Pharmaceutical Laboratories, Ltd v. [read post]
1 Dec 2011, 6:25 am
At SCOTUSblog, Ronald Mann previews next Monday’s arguments in Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
21 Nov 2011, 5:35 pm
Supreme Court is scheduled to hear Oral Argument in Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
27 Jul 2011, 4:06 pm
See Novo Nordisk A/S v. [read post]
6 Jul 2011, 10:52 am
Supreme Court in Mensing and Sorrell (here and here), and the Court’s decision to hear Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
3 Jul 2011, 11:08 pm
Hyatt; Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
29 Jun 2011, 7:19 am
First, the court agreed to hear a case involving the Hatch-Waxman Act’s counterclaim provision and patent use codes ( Caraco Pharmaceutical Laboratories Ltd. v. [read post]
27 Jun 2011, 9:18 am
Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
27 Jun 2011, 8:41 am
Petitioners’ reply Amicus brief of Parents Television Council Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
27 Jun 2011, 8:16 am
Hyatt (whether a petitioner appealing PTO denials of patent applications in federal court can rely on new evidence not presented to the agency) and Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
24 Jun 2011, 3:25 pm
Certiorari stage documents:Opinion below (6th Circuit) Petition for certiorari Brief in opposition CVSG Information:Invited: February 28, 2011Filed: May 26, 2011 (Deny) Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
27 May 2011, 8:56 am
Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
28 Mar 2011, 7:32 am
Novo Nordisk A/SDocket: 10-844Issue(s): Whether the counterclaim provision of the Hatch-Waxman Act applies when (1) there is “an approved method of using the drug” that “the patent does not claim,” and (2) the brand submits “patent information” to the FDA that misstates the patent's scope, requiring “correct[ion]. [read post]
24 Mar 2011, 12:53 pm
Rodriguez Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
29 Dec 2010, 2:57 am
Sandoz, Inc (IPBiz) (Patent Docs) Plavix (Clopidogrel) – Brazil: Superior Court of Justice denies Plavix patent extension (IP tango) Prandin (Repaglinide) – US: Novo Nordisk and Sandoz settle infringement claims in Prandin dispute (Patent Docs) Prandin (Repaglinide) – US: Supreme Court petitioned to review Federal Circuit patent use code decision: Caraco v Novo Nordisk (FDA Law Blog) [read post]
28 Dec 2010, 10:58 am
Caraco Pharmaceutical Laboratories, Ltd., 601 F.3d 1359 (Fed. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
3 Sep 2010, 11:42 am
Caraco Pharmaceutical Laboratories, Ltd. handed down earlier this year by the U.S. [read post]
18 Aug 2010, 12:19 am
Novo Nordisk Pharmaceuticals Pty Ltd; Zetco Pty Ltd v. [read post]
